188 related articles for article (PubMed ID: 14750534)
1. Hypothesis: the act of taking a Papanicolaou smear reduces the prevalence of human papillomavirus infection: a potential impact on the risk of cervical cancer.
Shapiro S; Carrara H; Allan BR; Hoffman M; Rosenberg L; Kelly JP; Cooper DD; Williamson AL
Cancer Causes Control; 2003 Dec; 14(10):953-7. PubMed ID: 14750534
[TBL] [Abstract][Full Text] [Related]
2. Women's knowledge of Pap smear test and human papillomavirus: acceptance of HPV vaccination to themselves and their daughters in an Islamic society.
Ilter E; Celik A; Haliloglu B; Unlugedik E; Midi A; Gunduz T; Ozekici U
Int J Gynecol Cancer; 2010 Aug; 20(6):1058-62. PubMed ID: 20683417
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
Castle PE; Wacholder S; Lorincz AT; Scott DR; Sherman ME; Glass AG; Rush BB; Schussler JE; Schiffman M
J Natl Cancer Inst; 2002 Sep; 94(18):1406-14. PubMed ID: 12237286
[TBL] [Abstract][Full Text] [Related]
4. The determination of the knowledge level and behavior of Turkish women from various occupations about human papillomavirus, cervical cancer, and pap smear test.
Cimke VS; Borekci G
J Cancer Res Ther; 2019; 15(6):1235-1244. PubMed ID: 31898654
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, Belgium.
Vorsters A; Cornelissen T; Leuridan E; Bogers J; Vanden Broeck D; Benoy I; Goossens H; Hens N; Van Damme P
BMC Public Health; 2016 Jun; 16():477. PubMed ID: 27266509
[TBL] [Abstract][Full Text] [Related]
6. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
7. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
[TBL] [Abstract][Full Text] [Related]
8. Papanicolaou smears induce partial immunity against sexually transmitted viral infections.
Shapiro S; Hoffman M; Constant D; Rosenberg L; Carrara H; Allan BR; Marais DJ; Passmore JA; Williamson AL
Epidemiology; 2007 Nov; 18(6):709-15. PubMed ID: 18049186
[TBL] [Abstract][Full Text] [Related]
9. High-risk human papillomavirus infection and abnormal cervical cytology among Nepali and Bhutanese refugee women living in eastern Nepal.
Bhatta MP; Johnson DC; Lama M; Aryal S; Lhaki P; Shrestha S
BMC Infect Dis; 2017 Jan; 17(1):73. PubMed ID: 28088173
[TBL] [Abstract][Full Text] [Related]
10. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.
Castellsagué X; Díaz M; Vaccarella S; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Meijer CJ; Bosch FX
Lancet Oncol; 2011 Oct; 12(11):1023-31. PubMed ID: 21917519
[TBL] [Abstract][Full Text] [Related]
11. Community-Based Screening for Cervical Cancer: A Feasibility Study of Rural Appalachian Women.
Crosby RA; Hagensee ME; Vanderpool R; Nelson N; Parrish A; Collins T; Jones N
Sex Transm Dis; 2015 Nov; 42(11):607-11. PubMed ID: 26462184
[TBL] [Abstract][Full Text] [Related]
12. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
13. Limited Pap screening associated with reduced risk of cervical cancer in South Africa.
Hoffman M; Cooper D; Carrara H; Rosenberg L; Kelly J; Stander I; Williamson AL; Denny L; du Toit G; Shapiro S
Int J Epidemiol; 2003 Aug; 32(4):573-7. PubMed ID: 12913031
[TBL] [Abstract][Full Text] [Related]
14. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
[TBL] [Abstract][Full Text] [Related]
15. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention.
Moreira ED; Oliveira BG; Ferraz FM; Costa S; Costa Filho JO; Karic G
Int J Gynecol Cancer; 2006; 16(2):599-603. PubMed ID: 16681732
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Human Papillomavirus Genotypes and Abnormal Pap Smears Among Women in the Military Health System.
Daly CM; Hansen SL; Kwon PO; Roberts TA
J Community Health; 2018 Jun; 43(3):441-447. PubMed ID: 29168085
[TBL] [Abstract][Full Text] [Related]
17. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
Othman N; Othman NH
Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
[TBL] [Abstract][Full Text] [Related]
18. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
Touch S; Oh JK
BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
Guo F; Hirth JM; Berenson AB
J Womens Health (Larchmt); 2017 Oct; 26(10):1114-1122. PubMed ID: 28841084
[TBL] [Abstract][Full Text] [Related]
20. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
Soccio J; Brown M; Comino E; Friesen E
J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
